<< Read Full Article
<< Read Full Article
Geron Running Again
Geron's (GERN Quote) vital signs keep getting stronger.
The biotechnology company, which enjoyed a muscular rally following coverage by TheStreet.com earlier this week, extended its gains after reporting a new medical breakthrough on Thursday. In a preview of an article due out by Stem Cells in August, the company unveiled fresh progress on a stem cell-related treatment for diabetes.
Specifically, Geron said that it has differentiated embryonic stem cells into clusters that "secrete insulin in response to elevated glucose levels." The advance could offer hope for huge crowds of people who suffer from type 1 diabetes. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet